Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department

EMA - Emergency Medicine Australasia

Volumn 16, Issue 1, 2004, Pages 47-54

  Graham, Colin A ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Acute; Cardiogenic pulmonary oedema; Drug therapy; Emergency department

Indexed keywords

BUMETANIDE; CAPTOPRIL; DIAMORPHINE; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; ISOSORBIDE; LEVOSIMENDAN; MORPHINE; NALOXONE; NESIRITIDE; NITRATE; PRAZOSIN; SILDENAFIL; TEZOSENTAN;

CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFECT; DRUG ELIMINATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; EMERGENCY TREATMENT; EMERGENCY WARD; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; HYPOTENSION; LUNG EDEMA; OXYGEN THERAPY; PRIORITY JOURNAL; REVIEW;

EID: 1942542079     PISSN: 17426731     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2004.00534.x     Document Type: Review

References (46)

1. Fromm Jr RE, Varon J, Gibbs LR. Congestive heart failure and pulmonary edema for the emergency physician. J. Emerg. Med. 1995; 13: 71-87.
2. Mattu A. Cardiogenic pulmonary edema. Current Opinion in Cardiovascular, Pulmonary and Renal Investigational Drugs 2000; 2: 9-16.
3. Jackson G, Gibbs CR, Davies MK, Lip GY. ABC of heart failure: Pathophysiology. BMJ 2000; 320: 167-70.
4. Cotter G, Kaluski E, Moshkovitz Y, Milovanov O, Krakover R, Vered Z. Pulmonary edema: new insight on pathogenesis and treatment. Current Opinion Cardiol. 2001; 16: 159-63.
5. Jackson R, Carley S. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. CPAP in acute left ventricular failure. Emerg. Med. J. 2001; 18: 63-4.
6. Kelly A-M, Georgakas C, Bau S, Rosengarten P. Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency management of acute severe cardiogenic pulmonary oedema. Aust. NZ J. Med. 1997; 27: 319-22.
7. Sharon A, Shpirer I, Kaluski E et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J. Am. College Cardiol. 2000; 36: 832-7.
8. Mehta S, Jay GD, Woolard RH et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit. Care Med. 1997; 25: 620-8.
9. Adnet F, Le Toumelin P, Leberre A et al. In-hospital and long-term prognosis of elderly patients requiring endotracheal intubation for life-threatening presentation of cardiogenic pulmonary edema. Crit. Care Med. 2001; 29: 891-5.
10. Cotter G, Metzkor E, Kaluski E et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-93.
11. Davies MK, Gibbs CR, Lip GY. ABC of heart failure: Investigation. BMJ 2000; 320: 297-300.
12. Davie AP, Francis CM, Love MP et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996; 312: 222.
13. Diamond NJ, Schofferman J, Elliot JW. Arterial blood gases in acute pulmonary edema. JACEP 1976; 5: 497-500.
14. Wuerz RC, Meador SA. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann. Emerg. Med. 1992; 21: 669-74.
15. Sacchetti AD, Harris RH. Acute cardiogenic pulmonary edema. What's the latest in emergency treatment? Postgraduate Med 1998; 103: 145-7.
16. Cotter G, Vered Z, Shpirer I. Support ventilation versus conventional oxygen. Lancet 2001; 357: 1125.
17. Aberman A, Fulop M. The metabolic and respiratory acidosis of acute pulmonary edema. Ann. Intern. Med. 1972; 76: 173-84.
18. Millane T, Jackson G, Gibbs CR, Lip GY. ABC of heart failure: Acute and chronic management strategies. BMJ 2000; 320: 559-62.
19. Hoffman JR, Reynolds S. Comparison of nitroglycerin, morphine and furosemide in treatment of presumed prehospital pulmonary edema. Chest 1987; 92: 586-93.
20. Sacchetti A, Ramoska E, Moakes ME, McDermott P, Moyer V. Effect of ED management on ICU use in acute pulmonary edema. Am. J. Emerg. Med. 1999; 17: 571-4.
21. Vismara LA, Leaman DM, Zelis R. The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 1976; 54: 335-7.
22. Grossmann M, Abiose A, Tangphao O, Blaschke TF, Hoffman BB. Morphine-induced venodilation in humans. Clin. Pharmacol. Ther. 1996; 60: 554-60.
23. Chambers JA, Baggoley CJ. Pulmonary oedema-prehospital treatment: Caution with morphine dosage. Med. J. Aust. 1992; 157: 326-8.
24. Figueras J, Weil MH. Blood volume prior to and following treatment of acute cardiogenic pulmonary edema. Circulation 1978; 57: 349-55.
25. Northridge D. Frusemide or nitrates for acute heart failure? Lancet 1996; 347: 667-8.
26. Stanke F, Devillier P, Breant D et al. Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscle. Br. J. Clin. Pharmacol. 1998; 46: 571-5.
27. De Bruyne LKM. Mechanisms and management of diuretic resistance in congestive heart failure. Postgrad. Med. J. 2003; 79: 268.
28. Gammage M. Treatment of acute pulmonary oedema: diuresis or vasodilatation? Lancet 1998; 351: 382-3.
29. Khot UN, Novaro GM, Popovic ZB et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N. Engl. J. Med. 2003; 348: 1756-63.
30. Tran D, Howes LG. Cardiovascular safety of sildenafil. Drug Safety 2003; 26: 453-60.
31. Boyce EG, Umland EM. Sildenafil citrate: a therapeutic update. Clin. Therapeutics 2001; 23: 2-23.
32. Forrester JS, Waters DD. Hospital treatment of congestive heart failure: Management according to hemodynamic profile. Am J. Med. 1978; 65: 173-80.
33. Harf C, Welter R. Emergency treatment of severe cardiogenic pulmonary edema with intravenous isosorbide-5-mononitrate. Am. J. Cardiol. 1988; 61: 22E-7E.
34. Bertini G, Giglioli C, Biggeri A et al. Intravenous nitrates in the prehospital management of acute pulmonary edema. Ann. Emerg. Med. 1997; 30: 493-9.
35. Hess B. Chronic heart failure: pathophysiology and therapeutic approaches - why is the kidney so important? Eur. Heart J. Supplements 2001; 3: G3-G7.
36. Christenson JM. Captopril in acute pulmonary edema: Measuring the benefit. Acad Emerg. Med. 1996; 3: 192-3.
37. Hamilton RJ, Carter WA, Gallagher EJ. Rapid improvement of acute pulmonary edema with sublingual captopril. Acad. Emerg. Med. 1996; 3: 205-12.
38. Adigun AQ, Ajayi OE, Sofowora GG, Ajayi AA. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate. Int. J. Cardiol. 1998; 67: 81-6.
39. Hirschl MM, Schreiber W, Woisetschlager C, Kaff A, Raab H. [Sublingual nitroglycerin or intravenous enalaprilat in preclinical treatment of hypertensive patients with pulmonary edema]. Z Kardiol. 1999; 88:208-14. (In German.)
40. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. [Published erratum appears in JAMA 2002; 288: 577]. JAMA 2002; 287: 1531-40.
41. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. [Published erratum appears in JAMA 2002; 288: 577]. JAMA 2002; 287: 1531-40.
42. Keating GM, Goa KL. Nesiritide: a review of its use in acute decompensated heart failure. Drugs 2003; 63: 47-70.
43. Cleland JG, McGowan J. Levosimendan: a new era for inodilator therapy for heart failure? Current Opinion Cardiol. 2002; 17: 257-65.
44. Endoh M. Mechanisms of action of novel cardiotonic agents. J. Cardiovascular Pharmacol. 2002; 40: 323-38.
45. Cotter G, Kiowski W, Kaluski E et al. Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure. Eur. J. Heart Fail. 2001; 3: 457-61.
46. Kaluski E, Kobrin I, Zimlichman R et al. RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study. J. Am. College Cardiol. 2003; 41: 204-10.